AKCA insider filings
AKCEA THERAPEUTICS, INC. — 18 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2020-10-14. Screen AKCA transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AKCA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — AKCEA THERAPEUTICS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2020-10-14 | 4 | IONIS PHARMACEUTICALS INC — 10% owner | Purchase (P): 21,237,715 @ $18.15 | EDGAR |
| 2020-10-13 | 4 | Patterson Joshua F. — General Counsel | Code (U): 26,532 @ $18.15 · Disposition to issuer (D): 13,750 (derivative) @ $1.16 · Disposition to issuer (D): 7,500 (derivative) @ $5.39 | EDGAR |
| 2020-10-13 | 4 | Jenne Kyle — Chief Commercial Officer | Code (U): 52,012 @ $18.15 · Disposition to issuer (D): 143,374 (derivative) @ $5.94 · Disposition to issuer (D): 32,751 (derivative) @ $5.94 · Disposition to issuer (D): 299 (derivative) @ $0.77 · Disposition to issuer (D): 13,701 (derivative) @ $0.77 · Disposition to issuer (D): 34,200 (derivative) @ $5.39 | EDGAR |
| 2020-10-13 | 4 | Howarth Alex G. — Chief Operating Officer | Code (U): 66,800 @ $18.15 · Disposition to issuer (D): 300,000 (derivative) @ $0.21 · Disposition to issuer (D): 34,200 (derivative) @ $5.39 | EDGAR |
| 2020-10-13 | 4 | McDevitt Damien — Chief Executive Officer, Director | Code (U): 242,978 @ $18.15 · Disposition to issuer (D): 120,000 (derivative) @ $5.39 · Disposition to issuer (D): 200,000 (derivative) @ $5.39 | EDGAR |
| 2020-10-13 | 4 | YANG MICHAEL J. — Director | Disposition to issuer (D): 26,400 (derivative) @ $2.01 | EDGAR |
| 2020-10-13 | 4 | Salzman Amber — Director | Disposition to issuer (D): 53,000 (derivative) @ $0.21 · Disposition to issuer (D): 26,400 (derivative) @ $2.01 | EDGAR |
| 2020-10-13 | 4 | Hochberg Elaine — Director | Disposition to issuer (D): 52,837 (derivative) @ $5.94 · Disposition to issuer (D): 26,400 (derivative) @ $2.01 | EDGAR |
| 2020-10-13 | 4 | Andrews William T. — Chief Medical Officer | Code (U): 37,500 @ $18.15 · Disposition to issuer (D): 250,000 (derivative) @ $4.86 | EDGAR |
| 2020-10-13 | 4 | Yanni Barbara — Director | Disposition to issuer (D): 26,400 (derivative) @ $2.01 | EDGAR |
| 2020-10-13 | 4 | PRICE MICHAEL DENNIS — Chief Financial Officer | Code (U): 50,000 @ $18.15 · Disposition to issuer (D): 300,000 (derivative) @ $3.37 | EDGAR |
| 2020-10-13 | 4 | SMITH SANDFORD D — Director | Disposition to issuer (D): 52,837 (derivative) @ $5.94 · Disposition to issuer (D): 26,400 (derivative) @ $2.01 | EDGAR |
| 2020-10-13 | 4 | KLEIN JOSEPH III — Director | Disposition to issuer (D): 26,400 (derivative) @ $2.01 | EDGAR |
| 2020-10-13 | 4 | PARSHALL B LYNNE — Director | Disposition to issuer (D): 26,400 (derivative) @ $2.01 | EDGAR |
| 2020-09-24 | 4 | Patterson Joshua F. — General Counsel | Sale (S): 319 @ $18.12 | EDGAR |
| 2020-09-24 | 4 | Jenne Kyle — Chief Commercial Officer | Sale (S): 720 @ $18.12 | EDGAR |
| 2020-09-24 | 4 | McDevitt Damien — Chief Executive Officer, Director | Sale (S): 8,709 @ $18.12 | EDGAR |
| 2020-09-02 | 4 | McDevitt Damien — Chief Executive Officer, Director | Grant/award (A): 1,104 @ $14.40 | EDGAR |
Recent 8-K events — AKCEA THERAPEUTICS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2020-10-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-08-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AKCA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs